TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition
MERGERS AND ACQUISITIONS

More Immunotherapy Buyouts Likely After Kite Sale

PowerShares QQQ Set an All-Time Intraday High; Diamonds, Spiders on the Cusp of Breaking-Out
INVESTING

Faster Rebuild After Harvey; Micron Tech Breakout Would Be a Win: Best of Cramer

Allergan 'Very Attractive' After Buybacks, Dividend Increase -Cramer Says
INVESTING

How a Girl From India is Now Ruling the M&A World

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)
JIM CRAMER

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap

Singer's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth
OPINION

Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI

Juno Therapeutics Stock Climbs, Wedbush Sees Advantages from Gilead, Kite Deal
STOCKS

Juno Therapeutics Stock Climbs, Wedbush Sees Advantages from Gilead, Kite Deal

Apple Gains Put Dow on Track for Sixth Straight Record Close
JIM CRAMER

Markets Focus on Business: Cramer's 'Mad Money' Recap

Stocks Close Mixed as Wall Street Struggles With Houston's Harvey Disaster
FUTURES

Stocks Close Mixed as Wall Street Struggles With Houston's Harvey Disaster

FTC Approves Abbott's Acquisition of Alere, Stock Jumps
STOCKS

FDA Approves Abbott Heart Device, Stock Rises

Harvey and Energy Markets - 5 Things You Must Know Before the Market Opens
FUTURES

Stocks Mixed as Insurers, Energy Firms Struggle to Wade Through Harvey Damage

Jim Cramer on Expedia, Uber, General Electric, Procter & Gamble, Western Digital, Gilead Sciences, Kite Pharma, Apple, Amazon, Whole Foods and Best Buy
VIDEO

Jim Cramer on Expedia, Uber, General Electric, Procter & Gamble, Western Digital, Gilead Sciences, Kite Pharma, Apple, Amazon, Whole Foods and Best Buy

Midday Report: Stocks Mixed as Hurricane Harvey Damage Assessed
VIDEO

Midday Report: Stocks Mixed as Hurricane Harvey Damage Assessed

Jim Cramer Reacts to the Gilead Sciences-Kite Pharma Acquisition
VIDEO

Jim Cramer Reacts to the Gilead Sciences-Kite Pharma Acquisition

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead
FUTURES

Stocks Mixed as Travelers Weighs on Dow Amid Harvey Damage Assessments

Kite Pharma Discloses CAR-T Patient Death, Rattling Investors
HEALTH

Kite Soars on Sale to Gilead - Biotech Movers

Stock Futures Higher as Yellen Says Fed to Begin Unwinding Balance Sheet in 2017
FUTURES

Stock Futures Higher as Harvey Rattles Energy Markets

5 Cheap Cruise Vacations That Are Perfect for Alleviating Work Burnout
JIM CRAMER

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

One Auto Insurance Claim Can Cost You a Lot
JIM CRAMER

What's Getting In This Rally's Way: Cramer's 'Mad Money' Recap

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round
JIM CRAMER

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Market Selloff Survival Strategies: Cramer's 'Mad Money' Recap (Thurs 9/21/17)
JIM CRAMER

Reversal of Fortunes: Cramer's 'Mad Money' Recap

Novartis' CAR-T Gene Therapy Receives FDA Approval
REGULATION

Recommendation for Novartis May Give New Hope For Some Cancer Patients

Novartis' CAR-T Gene Therapy Receives FDA Approval
REGULATION

Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday

FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite Pharma
STOCKS

FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite Pharma

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
STOCKS

Biotech Movers: Global Blood Shares Rise on PRIME Designation

Uber Sued Over Lack of Wheelchair-Accessible Vehicles
MERGERS AND ACQUISITIONS

Bonderman's Controversial Remarks at Uber Puts His Other Five Seats at Risk